Searched for
AMLODIPINE AND ATORVASTATIN
Alembic Pharma gets USFDA nod for generic high blood pressure treatment drugAlembic Pharmaceuticals announced that it has secured final approval from the USFDA for its generic amlodipine and atorvastatin tablets, us...- Drug pricing regulator fixes prices of 40 formulation drugsThe regulator has reduced the maximum retail price of a new class of drugs, including statins, diabetes drugs, cardiovascular and combinati...
- Zydus receives final approvals from USFDA for skin ointment, heart medicineThe group also received a final nod for Amlodipine and Atorvastatin Tablets USP that is administered for heart and cholesterol-related case...
- Sensex down over 300 points, Nifty tests 7,550; NCC down 7%The S&P BSE Sensex fell over 100 points amid high volatility witnsessed in trade on Monday.
- Twelve stocks in focus in Monday's tradeIndian markets are expected to trade lower. Here is a list of twelve stocks which are likely to remain in focus today.
- Dr Reddy's recalls over 55K bottles of hypertension drug in USDr Reddy's Laboratories is recalling over 55,000 bottles of Amlodipine besylate and Atorvastatin calcium tablets.
- Dr Reddy's Laboratories recalls anti-seizure, hypertension drugs from US marketThe firm has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests.
- Dr Reddy's launches generic cholesterol-lowering drug in USDr Reddy's Laboratories shares were trading at Rs 2,594 apiece on the BSE in afternoon trade, down 1.60 per cent from its previous close.
- Indian pharma companies like Ranbaxy, Dr Reddy’s & others eye $1bn generic opportunityIn the wake of patent expiries on three blockbuster drugs over the last six-seven months, an opportunity worth nearly $1.3 billion is up fo...
- Ranbaxy Laboratories's net profit zooms four-fold at Rs 1,246 croreRanbaxy net profit jumped four fold to Rs 1,246 cr for the quarter ended Mar, buoyed by gains from two exclusive drug launches in US.
- Ranbaxy Laboratories launches generic Cadeut in the American marketDrug firm Ranbaxy Laboratories on Tuesday launched a generic version of Caduet, used for treating cardio vascular diseases, in the US marke...
- Glaxo, Pfizer’s patent claims turned downIndian authorities have rejected the patent applications of GlaxoSmithkline’s anti-diabetic drug Avandia and Pfizer’s cholesterol lowering ...
- Ranbaxy, Pfizer settle Lipitor litigation worldwideRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
Load More
